We are live on
!
Find out more
VCNX
Vaccinex, Inc. Common Stock
VCNX
VCNX
Delisted
VCNX was delisted on the 17th of December, 2024.
17 hedge funds and large institutions have $1.07M invested in Vaccinex, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
6% less funds holding
Funds holding: 18 → 17 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
63% less capital invested
Capital invested by funds: $2.92M → $1.07M (-$1.85M)
Holders
17
Holders Change
-1
Holders Change %
-5.56%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
3
Closed
6
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$2K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$27.1K |
| 2 |
Two Sigma Investments
New York
|
+$13.6K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$9.91K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.17K |
| 5 |
FCG
Financial Connections Group
Corte Madera,
California
|
+$225 |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
-$768K |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$231K |
| 3 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$53.6K |
| 4 |
Millennium Management
New York
|
-$15.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$10.4K |
